#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Penile squamous cell carcinoma Hepato-lenticular degeneration Gastric cancer Thalassaemia alpha Acute graft versus host disease Arrhythmogenic right ventricular dysplasia Measles Gastrooesophageal cancer Ornithine transcarbamoylase deficiency Glomerulonephritis membranoproliferative Anti-HLA antibody test positive Pustular psoriasis Immunodeficiency common variable Osteopetrosis Hepatic cirrhosis More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Diagnostics Mucous membrane pemphigoid Nephrotic syndrome Biotinidase deficiency Phenylketonuria – Basic Information Leukoencephalopathy – Treatment Mucopolysaccharidosis – Basic Information Primary hyperoxaluria Tuberous sclerosis complex – Diagnostics Hypereosinophilic syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SILYMARIN Tub-040 ZELENECTIDE PEVEDOTIN S227928 Emavusertib SODIUM HYDROXIDE Barium Sulfate Foscarnet Sodium Hexahydrate Ferric Carboxymaltose Simoctocog Alfa Adenosine Enoxaparin Sodium Rigosertib Sodium Quinapril Hydrochloride Chlorpromazine Hydrochloride Pentetic Acid Db-Oto-3 GOCATAMIG ARI0008 Opevesostat More therapies…

    Learn about Your Condition

    Ligament operation Radius fracture Lymphangiosarcoma Primary adrenal insufficiency Incisional hernia Coronary artery bypass Influenza Acute myeloid leukaemia Tympanic membrane perforation Follicular lymphoma stage III Optic ischaemic neuropathy Myasthenia gravis Vesicoureteric reflux Malignant melanoma stage III Habitual abortion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endometriosis

  • A study testing vipoglanstat for women with moderate to severe endometriosis-related pain

    Recruiting

    2 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • GS-248
    • VIPOGLANSTAT
    Bulgaria Czechia Hungary Italy Poland Romania

  • Study on Using Fluoroestradiol F-18 PET/CT for Detecting Endometriosis in Patients with Pain

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Fluoroestradiol F-18
    France

  • Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Ondansetron
    • Sodium Chloride
    The Netherlands

  • PET Imaging with [18F]AlF-FAPI-74 and Hyoscine Butylbromide in Patients Suspected of Endometriosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Hyoscine Butylbromide
    • [Al[18F]F]Fapi-74
    Belgium

  • Letrozole During IVF/ICSI for Women with Endometriosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Letrozole
    Belgium

  • Study of cabergoline compared to dienogest and ethinylestradiol for reducing endometriosis symptoms and lesion size in women with confirmed endometriosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Cabergoline
    • Ethinylestradiol
    Spain
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!